Highlights COVAXIN’s Human Trial Begins
Dr. Dangs Lab of Delhi claimed
Said- New Delhi selected as Central Lab for trial:
A private lab in Delhi has said that it has received an Indian-made vaccine for coronavirus. Covaxin’s Human Trial For this he has been selected to work with Bharat Biotech. On Wednesday, a statement from Dr. Dangs Lab said that it has been selected as a central lab for clinical trials on humans of Covaxin. Let me tell you that the Hyderabad company Bharat Biotech has created this vaccine in collaboration with Indian Council of Medical Research (ICMR) and Pune’s National Institute of Virology (NIV). On behalf of Dr. Dang’s Lab, it was said on Wednesday that it has partnered with Bharat Biotech to conduct the trial.
According to the statement issued by the lab, it is said that, ‘We are pleased to announce that Dr. Dangs Lab of Delhi is indigenously built for Kovid-19 in collaboration with ICMR and NIV on behalf of Bharat Biotech The vaccine has been selected as the central lab for the human clinical trial of the vaccine. It states that ‘all samples are being processed for screening and safety of several stages of the trial, after which the results will be studied in NIV’.
This lab is currently getting 50 to 100 samples every day from several testing sites for safety testing. The lab will speed up its operation to collect samples from 12 such testing sites in a fixed time this month. In a statement issued by the lab, it has been said that under the good clinical laboratory practice (GCLP) issued by the relevant regulatory bodies, quality care is being taken in the entire process. The lab has experts from every field who are working hard for a safe and effective Kovid-19 vaccine.
Video: Covaxin’s human trial, first round trial begins at 12 centers
(This news has not been edited by the NDTV team. It is published directly from the Syndicate feed.)